Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain-Reference-Cited by-同舟云学术

Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain

Published:2017-10-25 Issue:2 Volume:26 Page:361-374
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Sałat Kinga,Furgała Anna,Sałat Robert

Funder

Narodowe Centrum Nauki

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

http://link.springer.com/article/10.1007/s10787-017-0405-5/fulltext.html

Reference91 articles.

1. Argoff C (2011) Mechanisms of pain transmission and pharmacologic management. Curr Med Res Opin 27(10):2019–2031. doi: 10.1185/03007995.2011.614934

2. Baumhäkel M, Böhm M (2010) Recent achievements in the management of Raynaud’s phenomenon. Vasc Health Risk Manag 6:207–214

3. Bhalla S, Singh N, Jaggi AS (2015) Dose-related neuropathic and anti-neuropathic effects of simvastatin in vincristine-induced neuropathic pain in rats. Food Chem Toxicol 80:32–40. doi: 10.1016/j.fct.2015.02.016

4. Bird MF, Lambert DG (2015) Simultaneous targeting of multiple opioid receptor types. Curr Opin Support Palliat Care 9:98–102. doi: 10.1097/SPC.0000000000000129

5. Bombig MT, Ferreira C, Mora O et al (2003) Pravastatin protection from cold stress in myocardium of rats. Jpn Heart J 44(2):243–255

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naturally Inspired Molecules for Neuropathic Pain Inhibition—Effect of Mirogabalin and Cebranopadol on Mechanical and Thermal Nociceptive Threshold in Mice;Molecules;2023-11-30

2. Cebranopadol for the Treatment of Chronic Pain;Current Pain and Headache Reports;2023-08-09

3. KM-408, a novel phenoxyalkyl derivative as a potential anticonvulsant and analgesic compound for the treatment of neuropathic pain;Pharmacological Reports;2022-11-19

4. Cebranopadol as a Novel Promising Agent for the Treatment of Pain;Molecules;2022-06-21

5. Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation;CNS Drugs;2022-05-26